WK Form 144: Matthew Rizai plans to sell 40,000 shares ($3.50M)
Rhea-AI Filing Summary
Workiva Inc. insider Matthew M. Rizai notified a proposed sale of 40,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $3,499,992.00, to be sold approximately on 10/03/2025 on the NYSE. The filing states the shares were acquired on 10/03/2025 by a stock option exercise and paid for in cash. The notice also discloses prior sales by the same person in the past three months: 50,000 shares sold on 08/01/2025 for $3,882,500.00 and 100,000 shares sold on 07/14/2025 for $6,714,000.00. The filer represents they are not aware of any undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- Proposed sale of 40,000 shares by an insider scheduled for 10/03/2025
- Insider sold 150,000 shares in the prior three months (100,000 on 07/14/2025 and 50,000 on 08/01/2025)
Insights
Insider sold newly exercised options and previously sold 150,000 shares in 2 months.
What it means: The filing shows a proposed sale of 40,000 shares acquired by a stock option exercise on the same date and paid in cash, which is a routine liquidity event for option holders.
Why it matters: The same insider sold 100,000 and 50,000 shares on 07/14/2025 and 08/01/2025, respectively, totaling 150,000 shares previously; aggregated insider sales at this scale are material to shareholders monitoring insider trading activity.
FAQ
What does Workiva (WK) Form 144 filed by Matthew M. Rizai disclose?
How were the 40,000 shares acquired according to the filing?
Has Matthew M. Rizai recently sold other Workiva shares?
Through which broker will the proposed sale be executed?
Does the filer claim possession of any undisclosed material information?
On which exchange will the shares be sold?